Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats

Abstract

Objectives: To investigate the effect of silymarin and milk thistle extract on the progression of diabetic nephropathy (DN) in rats. Methods: Diabetes was induced with a single intraperitoneal (IP) injection of streptozotocin (STZ) (60 mgkg). Silymarin (100 mgkgd) or the extract (1.2 gkgd) was gavaged for 4 weeks. Blood glucose (BS), serum urea (Su), serum creatinine (Scr), and 24-h urine protein (Up) were measured and glomerular filtration rate (GFR) was calculated. Concentration of thiobarbituric acid reactive species (TBARS) and activities of glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT) were evaluated in the renal tissue. Results: Data were expressed as mean ± SEM. Silymarin or the extract had no significant effect on BS, Scr, and GFR. Both milk thistle extract and silymarin, respectively, decreased Su (mgdL) (87.1 ± 7.78, p < 0.001; 84.5 ± 7.15, p < 0.001), Up (mg) (5.22 ± 1.56, p=0.014; 5.67 ± 0.86, p=0.034), and tissue TBARS (nmolmg protein) (0.67 ± 0.04, p < 0.001; 0.63 ± 0.07, p < 0.001) in diabetic rats, compared to diabetic control (DC) (Su: 131.0 ± 4.55, Up: 8.3 ± 0.84, TBARS: 0.94 ± 0.06). Both the extract and silymarin could increase the activity of CAT (IUmg protein) (25.5 ± 4.0, p=0.005; 20 ± 1.8, p=0.16) and GPx (IUmg protein) (0.86 ± 0.05, p=0.005; 0.74 ± 0.04, p=0.10), respectively, in diabetic rats compared to DC (CAT 14.4 ± 2.0, GPx 0.57 ± 0.02). Conclusion: Milk thistle extract, to a lesser extent silymarin, can attenuate DN in rats possibly by increasing kidney CAT and GPx activity and decreasing lipid peroxidation in renal tissue. © Informa UK, Ltd.